1416-C EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN THE TREATMENT OF DECOMPENSATED CIRRHOTIC PATIENTS WITH CHRONIC HEPATITIS B You Deng 1 , Shuqian Zhang 1 , Wenya Chen 1 , Jiashuo Li 1 , Mengqi Li 1 , Qi Wang 1 , Hong Zhao 1 , Bing Qiao 2 and Wen Xie 1 , (1)Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China, (2)Qingdao Sixth People's Hospital Background: Hepatitis B viral (HBV) infection is a leading cause of liver cirrhosis and hepatocellular carcinoma (HCC) worldwide
Estos compuestos neutralizan radicales libres y previenen la peroxidacin lipdica, un proceso clave en el envejecimiento celular
Chandra, R., Hiniker, A., Kuo, Y
You can also learn more about the SkinMedica products mentioned above through our online store and have them conveniently shipped right to your home
Bottom line: STEP 1 trial (Wilding et al